These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 28334503

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Congenital malformations among babies born following letrozole or clomiphene for infertility treatment.
    Sharma S, Ghosh S, Singh S, Chakravarty A, Ganesh A, Rajani S, Chakravarty BN.
    PLoS One; 2014; 9(10):e108219. PubMed ID: 25272289
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clomiphene citrate and neural tube defects: a meta-analysis of controlled observational studies.
    Auffret M, Cottin J, Vial T, Cucherat M.
    BJOG; 2019 Aug; 126(9):1127-1133. PubMed ID: 31006176
    [Abstract] [Full Text] [Related]

  • 5. Post-Conceptional Exposure to Clomiphene Citrate and Congenital Malformations: A Cohort Study.
    Nehard R, Vauzelle C, Beghin D, Latour M, Elefant E, Coulm B, Marin B.
    Drug Saf; 2024 Sep; 47(9):883-894. PubMed ID: 38739233
    [Abstract] [Full Text] [Related]

  • 6. Risk of major congenital malformations following first-trimester exposure to vaginal azoles used for treating vulvovaginal candidiasis: a population-based retrospective cohort study.
    Rotem R, Fishman B, Daniel S, Koren G, Lunenfeld E, Levy A.
    BJOG; 2018 Nov; 125(12):1550-1556. PubMed ID: 29790255
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Aromatase inhibitors for subfertile women with polycystic ovary syndrome.
    Franik S, Kremer JA, Nelen WL, Farquhar C.
    Cochrane Database Syst Rev; 2014 Feb 24; (2):CD010287. PubMed ID: 24563180
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Extension of the clomiphene citrate stair-step protocol to gonadotropin treatment in women with clomiphene resistant polycystic ovarian syndrome.
    Horowitz E, Levran D, Weissman A.
    Gynecol Endocrinol; 2017 Oct 24; 33(10):807-810. PubMed ID: 28454491
    [Abstract] [Full Text] [Related]

  • 17. Risk of foetal harm with letrozole use in fertility treatment: a systematic review and meta-analysis.
    Pundir J, Achilli C, Bhide P, Sabatini L, Legro RS, Rombauts L, Teede H, Coomarasamy A, Zamora J, Thangaratinam S.
    Hum Reprod Update; 2021 Apr 21; 27(3):474-485. PubMed ID: 33374012
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis.
    Wang R, Li W, Bordewijk EM, Legro RS, Zhang H, Wu X, Gao J, Morin-Papunen L, Homburg R, König TE, Moll E, Kar S, Huang W, Johnson NP, Amer SA, Vegetti W, Palomba S, Falbo A, Özmen Ü, Nazik H, Williams CD, Federica G, Lord J, Sahin Y, Bhattacharya S, Norman RJ, van Wely M, Mol BW, Reproductive Medicine Network+, International Ovulation Induction IPDMA Collaboration.
    Hum Reprod Update; 2019 Nov 05; 25(6):717-732. PubMed ID: 31647106
    [Abstract] [Full Text] [Related]

  • 20. Potential Teratogenic Effects of Clomiphene Citrate.
    Scaparrotta A, Chiarelli F, Verrotti A.
    Drug Saf; 2017 Sep 05; 40(9):761-769. PubMed ID: 28547654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.